Market analyst Mitesh Thakkar has suggested four BUY Calls and no SELL Call for today’s trading session.

Pfizer announced that its vaccine developed by a German health startup has 90 percent efficacy.

Research house and brokerage Motilal Oswal has suggested BUY Call for pharmaceutical major Aurobindo Pharma with a target price of Rs 985.

Ace investor Rakesh Jhunjhunwala has raised his stake in Lupin during the last quarter. Pharmaceutical sector has witnessed strong performance after COVID-19 pandemic led to lockdowns.

Pharmaceutical major Wockhardt has signed a deal with the UK government to supply COVID-19 vaccine under development and testing by AstraZeneca and researchers from Oxford University.

Angel Broking has suggested two BUY Call for short term investors.